Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Growth, recognition, results—and an important partnership

Posted on January 17th, 2019 by in Pharma R&D

Here at Sigilon Therapeutics, we have had a very exciting period of growth recently, including receiving an Advanced Therapy Medicinal Product (ATMP) designation from the European Medicines Agency, adding two new members to our leadership team and initiating a collaboration with Eli Lilly in type 1 diabetes. Continue reading “Growth, recognition, results—and an important partnership” »

Drug Companies Collaborate to Take on the Opioid Crisis

Posted on November 8th, 2017 by in Pharma R&D

hands-1903104_640

The opioid crisis in the US is now responsible for taking more American lives each year than car crashes. Continue reading “Drug Companies Collaborate to Take on the Opioid Crisis” »

Emerging Oncology Drugs in Pharma R&D Pipeline

Posted on March 2nd, 2017 by in Pharma R&D

Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »

“If you gave the same NCE to two different companies……”

Posted on March 24th, 2016 by in Pharma R&D

You might think this is the opening line for a riddle, but in fact it forms the basis of IDEA Pharma’s Productive Innovation Index (PII for short), an annual ranking of the top 30 biopharmaceutical companies Continue reading ““If you gave the same NCE to two different companies……”” »